TYK Medicines (HKG:2410) said the Listing Committee of the Stock Exchange of Hong Kong approved the listing of the company's 173,641,645 H shares on the exchange on Monday, a same-day bourse filing said.
The said H shares are to be converted from the same number of unlisted shares held by 25 company shareholders. The exchange also granted permission to deal in the converted H shares to the company.
The company had applied to the Exchange for the conversion and listing of the said shares on Sept. 13, 2024.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.